As of April 2025 KOBAYASHI Pharmaceutical has a market cap of A$4.51 Billion. This makes KOBAYASHI Pharmaceutical the world's 3530th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | A$4.51 B | -5.88% |
2024 | A$4.79 B | -8.51% |
2023 | A$5.24 B | -30.47% |
2022 | A$7.54 B | -10.47% |
2021 | A$8.42 B | -32.23% |
2020 | A$12.43 B | 30.77% |
2019 | A$9.50 B | 25.08% |
2018 | A$7.59 B | 15.96% |
2017 | A$6.55 B | 32.84% |
2016 | A$4.93 B | 6.53% |
2015 | A$4.63 B | 57.06% |
2014 | A$2.94 B | 14.82% |
2013 | A$2.56 B | 36.64% |
2012 | A$1.87 B | -9.76% |
2011 | A$2.08 B | 11.66% |
2010 | A$1.86 B | 2.2% |
2009 | A$1.82 B | -28.52% |
2008 | A$2.55 B | 40.21% |
2007 | A$1.82 B | -6.84% |
2006 | A$1.95 B |
On Apr 5th, 2025 the market cap of KOBAYASHI Pharmaceutical was reported to be: